Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative
February 03, 2021 08:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, announced today they have partnered with...
Mariann Byerwalter joins Scipher Medicine’s Board of Advisors
December 01, 2020 08:00 ET
|
Scipher Medicine Corporation
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, has appointed Mariann Byerwalter to its Board of...
Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
September 11, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Metabolon Identifies Biomarkers with Superior Diagnostic Performance Over Creatinine for Chronic Kidney Disease
April 28, 2016 15:50 ET
|
Metabolon, Inc.
Data presented at National Kidney Foundation 2016 Spring Clinical MeetingsMetabolites form basis of accuGFR™ test in development RESEARCH TRIANGLE PARK, N.C., April 28, 2016 (GLOBE NEWSWIRE) --...
Metabolon and SYNLAB Group Form Commercialization Collaboration for Quantose™ IR Diagnostic
March 29, 2016 09:59 ET
|
Metabolon, Inc.
SYNLAB Group to market Quantose IR, a laboratory-developed test used to identify insulin resistanceInitial launch in SpainAdditional markets to follow in 2016 RESEARCH TRIANGLE PARK, N.C., March 29,...
Metabolon's Quantose(TM) Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech
September 17, 2014 11:05 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it has partnered with Metdia Biotech, S.L. to commercialize its...